1.
Osteoporosis
2006, Rheumatic disease clinics of North America, ISBN 9781416039044, Volume 32, no. 4., xii, p. 617-780
Book
Lancet, ISSN 0140-6736, 06/2006, Volume 367, Issue 9527, pp. 2010 - 2018
Osteoporosis is a serious public health issue. The past 10 years have seen great advances in our understanding of its epidemiology, pathophysiology, and...
Journal Article
2004, Best practice & research., Volume 18, no. 4., 463-629
Book
Nature, ISSN 0028-0836, 2012, Volume 491, Issue 7422, pp. 119 - 124
Crohn's disease and ulcerative colitis, the two common forms of inflammatory bowel disease (IBD), affect over 2.5 million people of European ancestry, with...
HYPER-IGE SYNDROME | RISK LOCI | NETWORK | NUMBER | METAANALYSIS | TUBERCULOSIS | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | MUTATIONS | EXPRESSION | Crohn Disease - genetics | Humans | Inflammatory Bowel Diseases - immunology | Colitis, Ulcerative - genetics | Mycobacterium tuberculosis - immunology | Inflammatory Bowel Diseases - physiopathology | Colitis, Ulcerative - immunology | Host-Pathogen Interactions - immunology | Mycobacterium tuberculosis - pathogenicity | Haplotypes - genetics | Mycobacterium - pathogenicity | Mycobacterium Infections - genetics | Inflammatory Bowel Diseases - genetics | Crohn Disease - microbiology | Mycobacterium Infections - microbiology | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Reproducibility of Results | Mycobacterium - immunology | Crohn Disease - immunology | Genome, Human - genetics | Phenotype | Colitis, Ulcerative - microbiology | Host-Pathogen Interactions - genetics | Polymorphism, Single Nucleotide - genetics | Inflammatory Bowel Diseases - microbiology | Crohn Disease - physiopathology | Colitis, Ulcerative - physiopathology | Inflammatory bowel disease | Candidates | Tuberculosis | Architecture | Genetics | Genomes | Diabetes | Gene expression | Health risk assessment | Immune system | Rheumatology and Autoimmunity | Basic Medicine | Medical Genetics | Medicinsk genetik | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | Medicinska och farmaceutiska grundvetenskaper | Klinisk medicin
HYPER-IGE SYNDROME | RISK LOCI | NETWORK | NUMBER | METAANALYSIS | TUBERCULOSIS | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | MUTATIONS | EXPRESSION | Crohn Disease - genetics | Humans | Inflammatory Bowel Diseases - immunology | Colitis, Ulcerative - genetics | Mycobacterium tuberculosis - immunology | Inflammatory Bowel Diseases - physiopathology | Colitis, Ulcerative - immunology | Host-Pathogen Interactions - immunology | Mycobacterium tuberculosis - pathogenicity | Haplotypes - genetics | Mycobacterium - pathogenicity | Mycobacterium Infections - genetics | Inflammatory Bowel Diseases - genetics | Crohn Disease - microbiology | Mycobacterium Infections - microbiology | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Reproducibility of Results | Mycobacterium - immunology | Crohn Disease - immunology | Genome, Human - genetics | Phenotype | Colitis, Ulcerative - microbiology | Host-Pathogen Interactions - genetics | Polymorphism, Single Nucleotide - genetics | Inflammatory Bowel Diseases - microbiology | Crohn Disease - physiopathology | Colitis, Ulcerative - physiopathology | Inflammatory bowel disease | Candidates | Tuberculosis | Architecture | Genetics | Genomes | Diabetes | Gene expression | Health risk assessment | Immune system | Rheumatology and Autoimmunity | Basic Medicine | Medical Genetics | Medicinsk genetik | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Reumatologi och inflammation | Medicinska och farmaceutiska grundvetenskaper | Klinisk medicin
Journal Article
2010, 2nd ed., Systems of the body, ISBN 9780702033773, 174
Book
2006, 1st, ISBN 0323034373, xvi, 289
Book
2006, 1st, ISBN 0323034373, xvi, 289
Book
Nature Genetics, ISSN 1061-4036, 05/2012, Volume 44, Issue 5, pp. 491 - 501
textabstractBone mineral density (BMD) is the most widely used predictor of fracture risk. We performed the largest meta-analysis to date on lumbar spine and...
WOMEN | POPULATION | IMPUTATION | VARIANTS | DISEASE | GENETICS & HEREDITY | OSTEOPOROTIC FRACTURES | GENE-EXPRESSION | LRP5 | PATTERNS | IMPUTED DATA | Glycoproteins - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Low Density Lipoprotein Receptor-Related Protein-5 - genetics | Extracellular Matrix Proteins - genetics | Humans | Risk Factors | Computational Biology | Intercellular Signaling Peptides and Proteins - genetics | European Continental Ancestry Group | Genotype | Male | Bone Density - genetics | Gene Expression Profiling | Phosphoproteins - genetics | Fractures, Bone - genetics | Mitochondrial Membrane Transport Proteins - genetics | Polymorphism, Single Nucleotide - genetics | Female | Femur Neck - physiopathology | Osteoporosis - genetics | Spectrin - genetics | Quantitative Trait Loci | Lumbar Vertebrae - physiopathology | Quantitative trait loci | Measurement | Fractures | Bones | Genetic aspects | Identification and classification | Density | Risk factors | Medical research | Osteoporosis | Genomics | Bone density | Gene loci | Vèrtebres lumbars | Gens | Femur | Genes | Bone densitometry | Densitometria òssia | Fèmur | Lumbar vertebrae | Basic Medicine | Medical Genetics | Medicinsk genetik | ortopedi | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | genetik | Genetics | Orthopaedics
WOMEN | POPULATION | IMPUTATION | VARIANTS | DISEASE | GENETICS & HEREDITY | OSTEOPOROTIC FRACTURES | GENE-EXPRESSION | LRP5 | PATTERNS | IMPUTED DATA | Glycoproteins - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Low Density Lipoprotein Receptor-Related Protein-5 - genetics | Extracellular Matrix Proteins - genetics | Humans | Risk Factors | Computational Biology | Intercellular Signaling Peptides and Proteins - genetics | European Continental Ancestry Group | Genotype | Male | Bone Density - genetics | Gene Expression Profiling | Phosphoproteins - genetics | Fractures, Bone - genetics | Mitochondrial Membrane Transport Proteins - genetics | Polymorphism, Single Nucleotide - genetics | Female | Femur Neck - physiopathology | Osteoporosis - genetics | Spectrin - genetics | Quantitative Trait Loci | Lumbar Vertebrae - physiopathology | Quantitative trait loci | Measurement | Fractures | Bones | Genetic aspects | Identification and classification | Density | Risk factors | Medical research | Osteoporosis | Genomics | Bone density | Gene loci | Vèrtebres lumbars | Gens | Femur | Genes | Bone densitometry | Densitometria òssia | Fèmur | Lumbar vertebrae | Basic Medicine | Medical Genetics | Medicinsk genetik | ortopedi | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | genetik | Genetics | Orthopaedics
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9671, pp. 1253 - 1263
Summary Background Persistent use of glucocorticoid drugs is associated with bone loss and increased fracture risk. Concurrent oral bisphosphonates increase...
Internal Medicine | BONE-DENSITY | WOMEN | MEDICINE, GENERAL & INTERNAL | SAFETY | ORAL CORTICOSTEROIDS | PERSISTENCE | BISPHOSPHONATE THERAPY | VERTEBRAL FRACTURE | CORTICOSTEROID-INDUCED OSTEOPOROSIS | ALENDRONATE | EPIDEMIOLOGY | Humans | Middle Aged | Male | Osteoporosis - drug therapy | Young Adult | Etidronic Acid - adverse effects | Aged, 80 and over | Diphosphonates - therapeutic use | Adult | Female | Etidronic Acid - therapeutic use | Imidazoles - therapeutic use | Risedronate Sodium | Diphosphonates - adverse effects | Etidronic Acid - analogs & derivatives | Glucocorticoids - adverse effects | Osteoporosis - chemically induced | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Bone Density - drug effects | Analysis of Variance | Adolescent | Least-Squares Analysis | Aged | Infusions, Intravenous | Clinical trials | Osteoporosis | Bones | Bone density | Acids | Older people | Index Medicus | Abridged Index Medicus
Internal Medicine | BONE-DENSITY | WOMEN | MEDICINE, GENERAL & INTERNAL | SAFETY | ORAL CORTICOSTEROIDS | PERSISTENCE | BISPHOSPHONATE THERAPY | VERTEBRAL FRACTURE | CORTICOSTEROID-INDUCED OSTEOPOROSIS | ALENDRONATE | EPIDEMIOLOGY | Humans | Middle Aged | Male | Osteoporosis - drug therapy | Young Adult | Etidronic Acid - adverse effects | Aged, 80 and over | Diphosphonates - therapeutic use | Adult | Female | Etidronic Acid - therapeutic use | Imidazoles - therapeutic use | Risedronate Sodium | Diphosphonates - adverse effects | Etidronic Acid - analogs & derivatives | Glucocorticoids - adverse effects | Osteoporosis - chemically induced | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Bone Density - drug effects | Analysis of Variance | Adolescent | Least-Squares Analysis | Aged | Infusions, Intravenous | Clinical trials | Osteoporosis | Bones | Bone density | Acids | Older people | Index Medicus | Abridged Index Medicus
Journal Article
Nature Reviews Endocrinology, ISSN 1759-5029, 02/2012, Volume 8, Issue 2, pp. 81 - 91
Antiresorptive therapies are used to increase bone strength in individuals with osteoporosis and include five principal classes of agents: bisphosphonates,...
ZOLEDRONIC ACID | HIP FRACTURE | SALMON-CALCITONIN | BONE-MINERAL DENSITY | VERTEBRAL FRACTURE RISK | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | CORTICOSTEROID-INDUCED OSTEOPOROSIS | POSTMENOPAUSAL WOMEN | SECONDARY OSTEOPOROSIS | ESTABLISHED PRIMARY OSTEOPOROSIS | Osteoporosis | Complications and side effects | Receptors | Diphosphonates | Calcitonin | Estrogen | Monoclonal antibodies | Dosage and administration | Drug therapy
ZOLEDRONIC ACID | HIP FRACTURE | SALMON-CALCITONIN | BONE-MINERAL DENSITY | VERTEBRAL FRACTURE RISK | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | CORTICOSTEROID-INDUCED OSTEOPOROSIS | POSTMENOPAUSAL WOMEN | SECONDARY OSTEOPOROSIS | ESTABLISHED PRIMARY OSTEOPOROSIS | Osteoporosis | Complications and side effects | Receptors | Diphosphonates | Calcitonin | Estrogen | Monoclonal antibodies | Dosage and administration | Drug therapy
Journal Article
Arthritis Research & Therapy, ISSN 1478-6354, 2012, Volume 14, Issue Suppl 2, pp. A17 - A17
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 02/2013, Volume 72, Issue 2, pp. 179 - 186
Background Strontium ranelate is currently used for osteoporosis. The international, double-blind, randomised, placebo-controlled Strontium ranelate Efficacy...
Thiophenes - therapeutic use | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Osteoarthritis, Knee - diagnostic imaging | Radiography | Organometallic Compounds - therapeutic use | Female | Aged | Osteoarthritis, Knee - drug therapy | Antirheumatic Agents - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Usage | Patient outcomes | Antiarthritic agents | Dosage and administration | Product/Service Evaluations | Drug therapy | Osteoarthritis | Knee | Osteoporosis | Pain management | Quality control | Arthritis | School dropout programs | Family medical history | Metabolism | Knee Osteoarthritis | Clinical and Epidemiological Research | 1507 | Outcomes research | 1506
Thiophenes - therapeutic use | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Osteoarthritis, Knee - diagnostic imaging | Radiography | Organometallic Compounds - therapeutic use | Female | Aged | Osteoarthritis, Knee - drug therapy | Antirheumatic Agents - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Usage | Patient outcomes | Antiarthritic agents | Dosage and administration | Product/Service Evaluations | Drug therapy | Osteoarthritis | Knee | Osteoporosis | Pain management | Quality control | Arthritis | School dropout programs | Family medical history | Metabolism | Knee Osteoarthritis | Clinical and Epidemiological Research | 1507 | Outcomes research | 1506
Journal Article